Toll Free: 1-888-928-9744

Lightlake Therapeutics Inc. - Product Pipeline Review - 2015

Published: Dec, 2015 | Pages: 23 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Lightlake Therapeutics Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Lightlake Therapeutics Inc. - Product Pipeline Review - 2015', provides an overview of the Lightlake Therapeutics Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Lightlake Therapeutics Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Lightlake Therapeutics Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Lightlake Therapeutics Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Lightlake Therapeutics Inc.'s pipeline products

Reasons To Buy

- Evaluate Lightlake Therapeutics Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Lightlake Therapeutics Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Lightlake Therapeutics Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Lightlake Therapeutics Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Lightlake Therapeutics Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Lightlake Therapeutics Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Lightlake Therapeutics Inc. Snapshot 4 Lightlake Therapeutics Inc. Overview 4 Key Information 4 Key Facts 4 Lightlake Therapeutics Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Lightlake Therapeutics Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Lightlake Therapeutics Inc. - Pipeline Products Glance 9 Lightlake Therapeutics Inc. - Clinical Stage Pipeline Products 9 Phase II Products/Combination Treatment Modalities 9 Phase I Products/Combination Treatment Modalities 10 Lightlake Therapeutics Inc. - Drug Profiles 11 naloxone hydrochloride 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 LT-21 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 LT-22 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Lightlake Therapeutics Inc. - Pipeline Analysis 15 Lightlake Therapeutics Inc. - Pipeline Products by Target 15 Lightlake Therapeutics Inc. - Pipeline Products by Route of Administration 16 Lightlake Therapeutics Inc. - Pipeline Products by Molecule Type 17 Lightlake Therapeutics Inc. - Pipeline Products by Mechanism of Action 18 Lightlake Therapeutics Inc. - Recent Pipeline Updates 19 Lightlake Therapeutics Inc. - Company Statement 20 Lightlake Therapeutics Inc. - Locations And Subsidiaries 21 Head Office 21 Appendix 22 Methodology 22 Coverage 22 Secondary Research 22 Primary Research 22 Expert Panel Validation 22 Contact Us 22 Disclaimer 23
List of Tables
Lightlake Therapeutics Inc., Key Information 4 Lightlake Therapeutics Inc., Key Facts 4 Lightlake Therapeutics Inc. - Pipeline by Indication, 2015 6 Lightlake Therapeutics Inc. - Pipeline by Stage of Development, 2015 7 Lightlake Therapeutics Inc. - Monotherapy Products in Pipeline, 2015 8 Lightlake Therapeutics Inc. - Phase II, 2015 9 Lightlake Therapeutics Inc. - Phase I, 2015 10 Lightlake Therapeutics Inc. - Pipeline by Target, 2015 15 Lightlake Therapeutics Inc. - Pipeline by Route of Administration, 2015 16 Lightlake Therapeutics Inc. - Pipeline by Molecule Type, 2015 17 Lightlake Therapeutics Inc. - Pipeline Products by Mechanism of Action, 2015 18 Lightlake Therapeutics Inc. - Recent Pipeline Updates, 2015 19



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify